Le Lézard
Classified in: Health, Business
Subject: CXP

PROCURE MARKS 6,000TH PATIENT TO COMPLETE TREATMENT


SOMERSET, N.J., Jan. 18, 2022 /PRNewswire/ -- ProCure Proton Therapy Center surpassed a major milestone Monday when Edmund Laska, 71, of Staten Island, NY, became its 6,000th patient to complete treatment since the center opened 10 years ago.

"We were truly honored to play a part in Mr. Laska's cancer journey," said Dr. Brian Chon, ProCure Medical Director. "Mr. Laska and patients like him put their trust in us, and we take that trust very seriously. Treating 6,000 patients is a testament to the great team we have at ProCure and the effectiveness of proton therapy."

ProCure, located in Somerset, NJ, became the tri-state region's first proton therapy facility in 2012. It treats a range of cancers, including diseases of the prostate, breast, lung, brain, head and neck, and gastrointestinal system, as well as sarcomas and many pediatric cases.

Proton therapy is a highly advanced form of radiation treatment that safely and precisely destroys cancer cells while sparing surrounding healthy tissue. Laska, who was diagnosed with prostate cancer in 2021, said proton therapy was an attractive treatment option because it has fewer side effects than traditional radiation therapy.

"It didn't hurt. I didn't feel a thing," Laska said. "When I get out of a treatment session, I continue my normal schedule."

"Before I was diagnosed, I was fortunate enough to know somebody who had treatment at ProCure and they guided me during the decision-making process," Laska added. "I had a leg up and would love to give back in the same way. Everyone at ProCure was super friendly and did everything they could to help you out. It is an honor to be their 6,000th patient."

"We would like to thank all of the fantastic physicians and institutions that we partnered with over the years, such as Princeton Radiation Oncology (now Astera Cancer Care), CentraState Medical Center, Memorial Sloan Kettering Cancer Center, Mount Sinai, Montefiore, NYU School of Medicine, Northwell Health, the Central New Jersey Division of Regional Cancer Care Associates and Hackensack Meridian Healthcare System. We are extremely grateful for the confidence entrusted upon us regarding the care of patients and their loved ones," said Tom Wang, president, ProCure Proton Therapy Center.

About ProCure Proton Therapy Center:
ProCure Proton Therapy Center in Somerset, NJ, opened in March 2012 as the tri-state region's first proton therapy facility, treating a range of cancers that includes diseases of the prostate, breast, lung, brain, head and neck, and gastrointestinal system, as well as sarcomas and many pediatric cases. Using the most advanced radiation treatment available, ProCure enables many cancer patients to choose a non-surgical treatment personalized to their medical needs and lifestyles, often with fewer side effects and less downtime?giving them more freedom to enjoy what matters most in their lives. For more information, visit ProCure.com.

Media Contact:
Sarah Ferrington, Marketing Manager
Phone: 732-357-2609
Email: [email protected] 

 

SOURCE ProCure Proton Therapy Center


These press releases may also interest you

at 03:25
Q1 2024 Key figures1 ? Revenue of EUR 1,439.5 million in the first quarter of 2024, up 2.5% year-on-year and up 8.0% organically ? Strong organic growth from Industry +16.3%, Certification +13.7%, Marine & Offshore +13.6%, compared to the first...

at 03:16
First quarter Net sales reached SEK 9.4 (13.0) million.The operating result totaled SEK -18.4 (-14.4) million.Earnings per share, basic and diluted, were SEK -0.11 (-0.09).Cash flow from operating activities totaled SEK -7.3 (-12.2) million.CEO...

at 03:09
Sungrow, the global leading PV inverter and energy storage system provider, released its annual report 2023 recently. The company attained unprecedented revenues and profits, fueled by robust demand across diverse global markets....

at 03:05
IG Canada, a premier online trading platform, is pleased to announce significant enhancements to its trading technology, designed to empower both novice and experienced traders with superior tools and resources. This development is part of IG...

at 03:03
International medical imaging IT and cybersecurity company Sectra (STO: SECT B) will provide its platform for medical education, Sectra Education Portal, to four university colleges in Denmark. With the solution, they aim to elevate the educational...

at 02:57
For Q1 2024, NORDEN reports a profit of USD 62 million (approx. DKK 435 million). Free cash flow in the first quarter amounted to USD -50 million (approx. DKK -350 million). Return on invested capital (ROIC) was 26% by end of Q1 based on the last...



News published on and distributed by: